RGEN Q3 2025 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q3 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$189M+21.9% YoY

Gross Profit

$101M53.2% margin

Operating Income

$17M8.9% margin

Net Income

$15M7.9% margin

EPS (Diluted)

$0.26

QoQ Revenue Growth

+3.5%

Cash Flow

Operating Cash Flow

$48M

Free Cash Flow

$43M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$841M

Stockholders' Equity

$2.1B

Cash & Equivalents

$749M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$189M	$155M	+21.9%
Gross Profit	$101M	$77M	+29.7%
Operating Income	$17M	-$8M	+314.8%
Net Income	$15M	-$654,000	+2380.0%

Revenue Segments

Product

$189M100%

Royalty

$39,0000%